Announced Fri, 24 Jul · 19:46 IST
Senior management changes - Preeti Kalra designated; Ravi Kumar resigns
Management Changes View source PDF
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
—1-day move
₹1649.00
prior close
₹1695.70
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.6-3.0-2.9-1.4——————————
Up moveDown movePending
AI summary
OneSource Specialty Pharma (formerly Stelis Biopharma) announced two changes in Senior Management Personnel effective July 24, 2026. Preeti Kalra, Head - HR with 25 plus years of experience across biopharma, insurance, IT and public services, was designated as SMP. Ravi Kumar, Global Head - Injectables and Head of Corporate Strategy, Portfolio and SPO, resigned from his SMP position. Filed under SEBI LODR Regulation 30.
Likely market impact
Senior management reshuffle. Ravi Kumar's exit from injectables and corporate strategy may create short-term leadership gaps. Preeti Kalra brings 25 plus years of HR experience.